GWM
GILD icon

Greenwich Wealth Management’s Gilead Sciences GILD Stock Holding History

Greenwich Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$952K Buy
6,832
+321
+5% +$45K 0.04% 157
2025
Q4 		$799K Sell
6,511
-264
-4% -$32.1K 0.04% 167
2025
Q3 		$752K Buy
6,775
+514
+8% +$58.4K 0.04% 168
2025
Q2 		$694K Sell
6,261
-273
-4% -$29.1K 0.03% 152
2025
Q1 		$732K Sell
6,534
-204
-3% -$21.1K 0.06% 139
2024
Q4 		$622K Sell
6,738
-219
-3% -$19.7K 0.04% 148
2024
Q3 		$583K Sell
6,957
-726
-9% -$55.4K 0.04% 155
2024
Q2 		$527K Buy
7,683
+299
+4% +$20K 0.04% 159
2024
Q1 		$541K Buy
7,384
+354
+5% +$27.2K 0.04% 159
2023
Q4 		$570K Sell
7,030
-104
-1% -$8.09K 0.06% 149
2023
Q3 		$535K Buy
7,134
+357
+5% +$27.5K 0.06% 145
2023
Q2 		$522K Buy
6,777
+315
+5% +$25.1K 0.05% 152
2023
Q1 		$536K Sell
6,462
-624
-9% -$51.7K 0.06% 149
2022
Q4 		$608K Sell
7,086
-330
-4% -$26.1K 0.07% 144
2022
Q3 		$458K Sell
7,416
-535
-7% -$33.7K 0.05% 159
2022
Q2 		$491K Sell
7,951
-21
-0.3% -$1.3K 0.07% 159
2022
Q1 		$474K Sell
7,972
-13
-0.2% -$831 0.05% 165
2021
Q4 		$580K Buy
7,985
+1,754
+28% +$121K 0.05% 150
2021
Q3 		$435K Buy
6,231
+882
+16% +$62K 0.04% 168
2021
Q2 		$368K Sell
5,349
-599
-10% -$40K 0.03% 168
2021
Q1 		$384K Sell
5,948
-106
-2% -$6.83K 0.03% 152
2020
Q4 		$353K Sell
6,054
-96
-2% -$5.79K 0.03% 144
2020
Q3 		$389K Buy
6,150
+129
+2% +$8.95K 0.07% 133
2020
Q2 		$463K Buy
6,021
+373
+7% +$28.6K 0.09% 121
2020
Q1 		$422K Sell
5,648
-262
-4% -$18.1K 0.09% 108
2019
Q4 		$384K Sell
5,910
-53
-0.9% -$3.45K 0.08% 141
2019
Q3 		$378K Sell
5,963
-957
-14% -$62.6K 0.07% 138
2019
Q2 		$468K Buy
6,920
+263
+4% +$17.3K 0.08% 125
2019
Q1 		$433K Buy
6,657
+169
+3% +$11.2K 0.08% 124
2018
Q4 		$406K Sell
6,488
-148
-2% -$10.3K 0.08% 119
2018
Q3 		$512K Buy
6,636
+288
+5% +$21.8K 0.09% 118
2018
Q2 		$450K Sell
6,348
-2,080
-25% -$147K 0.08% 120
2018
Q1 		$635K Buy
8,428
+203
+2% +$16.1K 0.1% 103
2017
Q4 		$589K Sell
8,225
-304
-4% -$23.1K 0.1% 107
2017
Q3 		$691K Sell
8,529
-722
-8% -$55.2K 0.12% 97
2017
Q2 		$655K Buy
9,251
+820
+10% +$54.6K 0.11% 100
2017
Q1 		$573K Sell
8,431
-2,472
-23% -$174K 0.08% 102
2016
Q4 		$781K Sell
10,903
-100
-0.9% -$7.43K 0.1% 102
2016
Q3 		$871K Sell
11,003
-50
-0.5% -$4.06K 0.15% 91
2016
Q2 		$922K Hold
11,053
– – 0.22% 86
2016
Q1 		$1.01M Sell
11,053
-1,034
-9% -$93.2K 0.26% 76
2015
Q4 		$1.22M Buy
12,087
+1,600
+15% +$166K 0.3% 63
2015
Q3 		$1.03M Sell
10,487
-12,385
-54% -$1.38M 0.25% 88
2015
Q2 		$2.68M Hold
22,872
– – 0.34% 77
2015
Q1 		$2.24M Buy
22,872
+300
+1% +$30.5K 0.25% 82
2014
Q4 		$2.13M Sell
22,572
-13,764
-38% -$1.42M 0.14% 88
2014
Q3 		$3.87M Hold
36,336
– – 0.26% 75
2014
Q2 		$3.01M Hold
36,336
– – 0.2% 79
2014
Q1 		$2.58M Hold
36,336
– – 0.18% 81
2013
Q4 		$2.73M Hold
36,336
– – 0.28% 83
2013
Q3 		$2.28M Hold
36,336
– – 0.16% 84
2013
Q2 		$1.86M Buy
+36,336
New +$1.89M 0.14% 86

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Greenwich Wealth Management's GILD Position: Q1 2026 in Review

Greenwich Wealth Management increased its Gilead Sciences (GILD) stake by 4.9% in Q1 2026, buying an estimated $45K and bringing the position to 6,832 shares worth $952K. The position accounts for 0.04% of the portfolio, ranked #157.

Greenwich Wealth Management first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.87M in Q3 2014. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Greenwich Wealth Management held 6,832 shares of Gilead Sciences worth $952K as of Q1 2026.
  • Greenwich Wealth Management bought 321 Gilead Sciences shares in Q1 2026, an estimated $45K.
  • Gilead Sciences made up 0.04% of Greenwich Wealth Management's portfolio in Q1 2026, its #157 holding.
  • Greenwich Wealth Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Greenwich Wealth Management's Gilead Sciences position peaked at $3.87M in Q3 2014.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Greenwich Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.